Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502709 · ClinicalTrials.gov registry record · NA
Neurostimulation in Temporomandibular Disorders (TMD) Patients
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01502709: Clinical Trial NA study, sponsored by University of North Carolina, Chapel Hill.
NCT01502709 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01502709, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators propose to conduct a randomized blinded placebo-controlled clinical trial in patients with chronic TMD (N=20). Patients will be randomly assigned to receive either active treatment (caloric vestibular neurostimulation) or placebo. Data will be collected prior to and after treatment on thermal and mechanical pain thresholds, clinical signs and symptoms of TMD, and any adverse events.
Primary Outcome
The mean of measures taken from days 1-7 was calculated. Pain was assessed by using VAS score ranges from 0 millimeter (mm) = no pain to 100 mm = worst possible pain. A decrease in score from Baseline represented treatment response.
Interventions
- DEVICE placebo
- DEVICE Caloric Vestibular Neurostimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-03 |
| Phase | NA |
Why NCT01502709 stopped before completion
NCT01502709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01502709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01502709 about?
NCT01502709 is a clinical study titled "Neurostimulation in Temporomandibular Disorders (TMD) Patients". The investigators propose to conduct a randomized blinded placebo-controlled clinical trial in patients with chronic TMD (N=20). Patients will be randomly assigned to receive either active treatment (caloric vestibular neurostimulation) or placebo. Data will be collected prior to and after treatment...
What is the current status of trial NCT01502709?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2011-12. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01502709?
The interventions under investigation include: placebo (DEVICE), Caloric Vestibular Neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT01502709?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01502709's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia